Trial intelligence / Profile preview

Difluprednate versus prednisolone acetate after phacoemulsification surgery

PACTR202207762785564Phase 3Unknown

Sponsor
Suez Canal University Hospital
Start
Jul 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of difluprednate and prednisolone in cataract (2 arms), sponsored by Suez Canal University Hospital. Primary endpoints: Efficacy, Safety and 1 more. Status: unknown.

02

Drugs

difluprednateprednisolone
03

Conditions

cataract

Beyond the preview

Go deeper on PACTR202207762785564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202207762785564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call